Company / Current Liabilities per Share
Vistagen Therapeutics, Inc. Current Liabilities per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.10
FY2021
5-year range
$0.10 / $0.88
FY2017-FY2021
Trend
-65.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.88 to $0.10 over the past 4 years.
Based on SEC 10-K filings.
0.10 in FY2021 with a 10-year CAGR of -16.6%.
Improved from $0.88 to $0.10 over the past 4 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -16.6%
Key checks
Key Insights
- In FY2021, current liabilities per share decreased 65.6% year-over-year.
- Peak current liabilities per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.10 | -65.6% |
| FY2018 | $0.29 | -67.4% |
| FY2017 | $0.88 | +557.7% |
| FY2014 | $0.13 | -53.5% |
| FY2012 | $0.29 | -52.8% |
| FY2011 | $0.61 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026